End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.009 USD | +800.00% | +164.71% | -98.56% |
Apr. 25 | Labcorp beats quarterly estimates on strong testing demand | RE |
Apr. 25 | Clinical lab operator Labcorp to buy bankrupt genetic test maker Invitae for $239 mln | RE |
Financials (USD)
Sales 2021 | 460M | Sales 2022 | 516M | Capitalization | 452M |
---|---|---|---|---|---|
Net income 2021 | -379M | Net income 2022 | -3.11B | EV / Sales 2021 | 8.98 x |
Net Debt 2021 | 679M | Net Debt 2022 | 1.2B | EV / Sales 2022 | 3.21 x |
P/E ratio 2021 |
-8.5
x | P/E ratio 2022 |
-0.14
x | Employees | 1,700 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 98.19% |
Latest transcript on Invitae Corporation
1 day | +800.00% | ||
1 week | +164.71% | ||
Current month | -18.18% | ||
1 month | -35.71% | ||
3 months | -97.64% | ||
6 months | -98.25% | ||
Current year | -98.56% |
Managers | Title | Age | Since |
---|---|---|---|
Randal Scott
FOU | Founder | 66 | 10-01-12 |
Kenneth Knight
CEO | Chief Executive Officer | 63 | 20-06-28 |
Ana Schrank
DFI | Director of Finance/CFO | - | 23-10-01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 67 | 15-11-03 | |
Randal Scott
FOU | Founder | 66 | 10-01-12 |
Eric Aguiar
BRD | Director/Board Member | 62 | 10-08-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.69% | 16 M€ | -8.49% | ||
0.63% | 1 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 0.009 | +800.00% | 1,428,884 |
24-04-24 | 0.001 | -72.22% | 178,541 |
24-04-23 | 0.0036 | +16.13% | 279,073 |
24-04-22 | 0.0031 | +106.67% | 444,994 |
24-04-19 | 0.0015 | -55.88% | 104,437 |
End-of-day quote OTC Markets, April 24, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-98.56% | 2.58M | |
-20.53% | 10.67B | |
+41.94% | 3.22B | |
-36.56% | 2.09B | |
-18.92% | 2.04B | |
-29.19% | 1.46B | |
+15.73% | 1B | |
-4.37% | 734M | |
-37.00% | 391M | |
-46.73% | 379M |
- Stock Market
- Equities
- NVTA.Q Stock